Monday November 23 2009 | Biotechnology feed | All feeds
|
|
News Articles on Regado Biosciences, Inc.Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6, 2009BASKING RIDGE, N.J., Oct. 5 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic Regado Biosciences Establishes Medical Advisory BoardBASKING RIDGE, N.J., June 2 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeut Regado Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry ConferenceBASKING RIDGE, N.J., March 30 /PRNewswire/ -- Regado Biosciences today announced that the Company's Chief Executive Officer, David J. Mazzo, P Regado Biosciences Selected to Present at InsideVenture's Debut Investor Conference March 25-26, Santa Barbara, CaliforniaBASKING RIDGE, N.J., March 17 /PRNewswire/ -- Regado Biosciences, Inc. today announced that David J. Mazzo, Ph.D., President and CEO of Regado Bios Regado Biosciences to Present at the 2009 Wharton Healthcare Business ConferenceBASKING RIDGE, N.J., Feb. 12 /PRNewswire/ -- Regado Biosciences, Inc. announced today that David J. Mazzo, Ph.D., President and Chief Executive Off Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical OfficerBASKING RIDGE, N.J., Jan. 15 /PRNewswire/ -- Regado Biosciences, Inc., announced today the appointment of Steven L. Zelenkofske, D.O., F.A.C.C. to Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare ConferenceBASKING RIDGE, N.J., Jan. 6 /PRNewswire/ -- Regado Biosciences, Inc. announced today that David J. Mazzo, Ph.D., President and Chief Executive Offi Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality AssuranceBASKING RIDGE, N.J. and DURHAM, N.C., Nov. 11 /PRNewswire/ -- Regado Biosciences, Inc., today announced the appointment of Alexander R. Giaquinto, Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation SystemDURHAM, N.C., Oct. 14 /PRNewswire/ -- Regado Biosciences, Inc., announced today the Company has completed enrollment in the Phase IIa clin Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008 MUNICH, Germany, Sept. 2 /PRNewswire/ -- Regado Biosciences, Inc.
announced today the presentation of comprehensive results from Phase Ia, Ib
a |
|